Interestingly, inhibition of cellular PP2A activity by OA sufficed to induce strong NELF-A phosphorylation in various cancer cell lines (H1299, A375, A431, and A549) even though a comparable level of ERK activity was observed before and after OA treatment in each cell line (Fig. 6i). The gene discussed is MAPK1; the disease is cancer.